AI-Driven Cell Factory Engineering

inquiry

Creative Enzymes applies computational systems biology and strain engineering to transform microbial hosts into optimized production systems. Our platform redesigns chassis metabolism, integrates heterologous pathways, and balances cellular resources to achieve commercially viable titers, rates, and yields.

Challenges in Cell Factory Development

Engineering microbes for industrial production confronts fundamental tensions between cellular fitness and human-defined production objectives:

Low production efficiency: Natural metabolism prioritizes growth and survival over product accumulation. Carbon flux to target products typically represents a small fraction of theoretical maximum, with the majority diverted to biomass or maintenance energy.
Pathway burden: Heterologous gene expression and protein synthesis impose substantial metabolic load. Ribosome allocation, amino acid consumption, and energy demand for transcription and translation compete with native functions essential for viability.
Host incompatibility: Foreign pathways introduce enzymes with incompatible cofactor preferences, suboptimal codon usage, or toxic intermediates that the host has not evolved to tolerate. Expression of these enzymes triggers stress responses that reduce productivity and genetic stability.
Metabolic imbalance: Overproduction of target compounds depletes precursor pools, exhausts cofactor supplies, and generates toxic byproducts. The host responds by downregulating pathway expression or selecting against production strains.

These challenges require chassis engineering that treats the host as a production platform to be optimized, not merely a container for introduced pathways.

AI-Assisted Cell Factory Platform

Host strain Optimization

Genome-scale modeling identifies genetic modifications that enhance precursor supply, eliminate competing pathways, and improve tolerance to product and process stress. Native regulatory networks are rewired to prioritize production over growth when advantageous.

Pathway Integration

Heterologous pathways are inserted at chromosomal loci that balance expression stability with minimal disruption to native metabolism. Codon optimization, promoter selection, and operon architecture are tuned for host-specific translation and transcription efficiency.

Metabolic Balancing

Carbon, energy, and redox flux are redistributed to support both growth and production. Dynamic control systems modulate pathway expression in response to cellular state, preventing metabolic overload during exponential phase and maximizing production during stationary phase.

Production Prediction

Machine learning models trained on fermentation datasets predict how strain genotype and process parameters combine to determine titer, rate, and yield. Predictions guide experimental prioritization and scale-up planning.

Fermentation Optimization

Process models identify optimal feeding strategies, pH profiles, and dissolved oxygen setpoints that match host metabolic capacity and pathway requirements. Scale-up parameters are predicted from laboratory data to reduce manufacturing risk.

Strain Engineering

Genome editing implements designed modifications with precision: knockouts of competing pathways, overexpression of rate-limiting enzymes, introduction of cofactor regeneration systems, and attenuation of feedback inhibition.

Engineering Workflow

1. Production Goal: Target product, required titer, and manufacturing constraints define the engineering objective. Feedstock, scale, and regulatory requirements inform host selection.

2. Host Analysis: Genome-scale modeling characterizes native metabolism: precursor availability, competing pathways, cofactor pools, and stress responses. Genetic stability and prior engineering history are evaluated.

3. Pathway Integration: Heterologous pathways are designed for chromosomal integration with optimized expression architecture. Codon usage, promoter strength, and operon organization are matched to host translational capacity.

4. AI Optimization: Metabolic models predict the impact of genetic modifications on growth and production. Multi-objective optimization identifies strain designs that balance yield with robustness and genetic stability.

5. Fermentation Validation: Engineered strains are characterized in bioreactor-relevant conditions. Growth, production, and metabolite profiles validate model predictions and inform iterative refinement.

Application Areas

Industrial Biotechnology

Manufacturing-scale production of chemicals, materials, and fuels in microbial hosts with improved process economics

Recombinant Protein Production

Optimized secretion and folding of therapeutic and industrial proteins with reduced aggregation and proteolytic degradation

Specialty Chemicals

High-value, low-volume products requiring precise stereochemistry and complex biosynthetic routes

Synthetic Biology

Programmable chassis for diverse bioproduction applications with modular pathway integration and rapid strain construction

Related Wet Lab Support

Services	Description	Price
Fermentation Development	Shake-flask and bioreactor characterization of engineered strains under process-relevant conditions. Fed-batch, continuous, and cell-recycle configurations are evaluated for optimal productivity.	Inquiry
Strain Engineering	Genome editing by CRISPR, recombineering, and transposon-mediated integration. Modifications include gene knockouts, promoter replacements, and pathway insertions with sequence-verified constructs.
Process Optimization	Systematic evaluation of media composition, feeding strategies, pH control, and dissolved oxygen for maximum titer and productivity. Scale-up parameters are established from laboratory data.

FAQs

Q: Which host organisms do you engineer?

A: E. coli, yeast (Saccharomyces cerevisiae, Pichia pastoris), and selected bacterial chassis. Host selection is guided by product requirements, pathway complexity, and manufacturing infrastructure.
Q: Can you improve existing production strains?

A: Yes. Genome-scale modeling of existing strains frequently reveals unused capacity, unidentified competing pathways, and regulatory constraints. Targeted engineering of these limitations often achieves substantial yield improvements.
Q: How do you handle genetic stability?

A: Chromosomal integration minimizes plasmid loss and copy number variation. Genome minimization removes mobile genetic elements and recombination hotspots. Production strains are monitored for genetic drift during extended cultivation.
Q: What is the typical timeline?

A: 10–16 months from target specification to validated production strain for moderate-complexity products. Strain improvement projects require 6–10 months.
Q: Do you support scale-up to manufacturing?

A: Yes. Fermentation development establishes process parameters at laboratory and pilot scale. Technology transfer packages support client manufacturing implementation.
Q: Can cell factory engineering integrate with pathway design?

A: Yes. Host chassis and heterologous pathways are co-designed to ensure metabolic compatibility. Pathway enzymes identified as bottlenecks are transferred to enzyme optimization services for kinetic improvement.

First Name:

Last Name:

Email *

Phone Number:

Company/Institution:

Country or Region:

Quantity:

Services & Products of Interested *

Project Description:

For research and industrial use only. Not intended for personal medicinal use. Certain food-grade products are suitable for formulation development in food and related applications.

Services

Online Inquiry